SET Announcements
The latest company disclosures have been updated, offering investors and stakeholders timely access to essential information.
24 February 2020
Management Discussion and Analysis Yearly Ending 31 Dec 2019
24 February 2020
Audited Yearly financial performance (F45)
24 February 2020
Financial Statement Yearly 2019 (Audited)
17 February 2020
Propose Agenda / Nominee Directors for Annual General Meeting to be held in 2020
06 February 2020
Completion of Investment in PT Futamed Pharmaceuticals ('FUTAMED'), Indonesia by Mega Lifesciences Public Company Limited
31 January 2020
Report of the utilization of capital increase from IPO
06 December 2019
Rights of Shareholders to propose agenda and to nominate candidates to be elected as Directors
20 November 2019
Notification of acquisition of 83.33% Equity Shares of PT Futamed Pharmaceuticals (Revised)
15 November 2019
Notification of acquisition of 83.33% Equity Shares of PT Futamed Pharmaceuticals
14 November 2019
Management Discussion and Analysis Quarter 3 Ending 30 Sep 2019
14 November 2019
Reviewed financial performance Quarter 3 (F45)
14 November 2019
